Stock Update for Spectrum Pharmaceuticals
Based on the most recent trading session, shares for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) closed at $18.63, with a change of -3.12%. 677,566 shares traded hands. Spectrum’s stock currently has an average trading capacity of 1.87 ... [Read]
Spectrum Pharmaceuticals, Inc. Doubles in Three Months – Here’s Why
Shares for Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) have more than doubled in the past three months. With a 110% increase, they are well beyond the comparable 5.3% rise of its corresponding industry. So where has this ... [Read]
This is Why Spectrum Pharmaceuticals Stock Soared in October
Spectrum Pharmaceuticals’ (NASDAQ:$SPPI) preliminary lung cancer data sparked a notable rally in its shares last month. Specifically, Spectrum, a small-cap oncology company, saw its shares gaining a whopping 29.2% in October, according to S&P Global ... [Read]
Spectrum Pharmaceuticals Announces Phase 2 Trial of Poziotinib
Last week, Spectrum Pharmaceuticals, Inc. (NASDAQ:$SSPI), announced the initiation of a Phase 2 trial of poziotinib in non-small cell lung cancer patients with Exon 20 insertion mutation in EGFR or HER2. The biotechnology company runs ... [Read]
Price Target Update on Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) plundered a cool -2.43% with the closing price of $18.90 as of morning trading. The overall volume in the last trading session was 2.7 million shares. ROI is a form of ... [Read]
Spectrum Pharmaceuticals Inc. Sees Price Target Raised by Jefferies Group LLC
In a research note from Monday, Jefferies Group LLC (NYSE:$JEF) raised its target price for Spectrum Pharmaceuticals Inc. (NASDAQ:$SPPI) stock from $13.00 to $18.00. This would indicate a potential upside of 26.05% from the company’s ... [Read]
Jefferies Group Issues Forecast for Spectrum Pharmaceuticals for Q3 2017
On Monday, Jefferies Group analysts listed their Q3 forecasts for Spectrum Pharmaceuticals Inc. (NASDAQ:$SPPI) stock. Analyst M. Andrews says the stock will likely increase from the prior quarter’s -$0.18 EPS and reach an EPS of -$0.16. ... [Read]
Head-to-Head: Spectrum Pharmaceuticals VS PTC Therapeutics
Two healthcare companies hitting new highs recently are Spectrum Pharmaceuticals (NASDAQ:$SPPI) and PTC Therapeutics (NASDAQ:$PTCT). However, where do you start when weighing them against each other? Let’s look at the stats. Spectrum Pharmaceuticals is a ... [Read]
The Road Ahead for Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) experienced a disappointing day during trading on Monday, September 18. The stock dipped -0.69% to a closing price of $10.10. The stock normally trades 894.52 million shares a day, but on ... [Read]
Analysts’ September Coverage Rating for Spectrum Pharmaceuticals
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) is a biotechnology company with a market cap of $857.70 million. The company specialized in the development and commercialization of oncology and hematology drugs. Despite operating through negative earnings currently, Spectrum ... [Read]